ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
HTCR
HeartCore Enterprises, Inc.
There isn't enough reported data to score HTCR yet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
HTCR Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Weak | |
| Strong |
HTCR's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
HTCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 0.4x | $1.34 | โ |
| Cheap | 0.5x | $1.65 | +23% |
| Fair | 0.8x | $2.59 | +94% |
| Expensive | 6.7x | $23.16 | +1629% |
Historical ranges are pointers, not guarantees.
HTCR's PE is 0.4x, but its earnings don't support one, so it isn't a reliable read right now.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
HTCR Forward outlook
There aren't enough analyst estimates for HTCR to show an outlook.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
HTCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.46 | +$3.86 |
| Q1 2026 | $5.71 | +$8.71 |
| Q4 2025 | $4.40 | +$5.80 |
| Q3 2025 | -$10.60 | -341% |
| Q2 2025 | -$0.40 | +$8.00 |
| Q1 2025 | -$3.00 | +$4.40 |
| Q4 2024 | -$1.40 | +$2.80 |
| Q3 2024 | $4.40 | +$7.00 |
HTCR has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over HTCR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was โ415% last quarter, up 694 points from the same quarter a year ago.
HTCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $321.4K | -93% |
| Q1 2026 | $1.2M | -65% |
| Q4 2025 | $1.9M | -44% |
| Q3 2025 | $3M | -83% |
| Q2 2025 | $4.7M | +17% |
| Q1 2025 | $3.6M | -29% |
| Q4 2024 | $3.4M | +3.5% |
| Q3 2024 | $17.9M | +281% |
HTCR's revenue has slid since its 2024 peak: $321,428 last quarter, down 93% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -256% | -259 points |
| Q1 2026 | -124% | -89 points |
| Q4 2025 | -66% | +220 points |
| Q3 2025 | -0.4% | -68 points |
| Q2 2025 | 2.3% | +39 points |
| Q1 2025 | -35% | -21 points |
| Q4 2024 | -286% | -191 points |
| Q3 2024 | 68% | +106 points |
HTCR has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
HTCR has the stronger cash trend. Its trailing FCF is up 21% versus its history, compared with ASTS at down 363%.
HTCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$1.2M | +$846.2K |
| Q4 2025 | -$136.1K | +$1.1M |
| Q3 2025 | -$306.1K | +$1.7M |
| Q4 2024 | -$1.3M | +$604.4K |
| Q3 2024 | -$2M | -$613.5K |
| Q4 2023 | -$1.9M | -$1.3M |
| Q3 2023 | -$1.4M | +$697.9K |
| Q2 2023 | -$491.5K | -271% |
HTCR has burned cash in most quarters: โ$3M over the past year, against โ$7M the year before.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HTCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | 10.1x | High |
| Q4 2024 | -0.6x | Net Cash |
| Q3 2024 | 0.1x | Very low |
| Q4 2021 | 18.6x | High |
| Q3 2021 | 7.6x | High |
HTCR has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
HTCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.5 | Oversold |
| Stochastic | 15.0 | Oversold |
HTCR's weekly RSI is 28 (oversold) and its Stochastic is 15 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
HTCR PE vs Technology Sector
| Metric | HTCR | Sector median | Relative |
|---|---|---|---|
| PE | 0.4x | 28x | 99% below |
| PE % | 2 | 49 | 47 pts below |
HTCR is trading at 0.4x earnings, a 99% discount to the Technology sector's median of 28x, though its earnings don't support one.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over HTCR on trend strength, trading above more of its moving averages.
HTCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.65 | 19% below |
| 20 week MA | $2.14 | 37% below |
| 50 week MA | $3.70 | 64% below |
| 100 week MA | $10.6 | 87% below |
| 200 week MA | $14.9 | 91% below |
HTCR is in a downtrend: it's below all five of its weekly moving averages, and 91% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS has the edge over HTCR on returns for 2026, with the stronger performance.
HTCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $82.6 | $16.4 | -80% |
| 2023 | $16.4 | $12.8 | -22% |
| 2024 | $12.8 | $31.0 | +143% |
| 2025 | $31.0 | $6.92 | -78% |
| 2026 YTD | $6.92 | $1.34 | -81% |
HTCR's yearly returns have swung widely, from +143% in 2024 to โ80% in 2022. It's down 81% so far in 2026.